Transient global amnesia following the use of ergots in the treatment of migraine;Amnesia global transitoria tras el uso de ergóticos en la migraña

Revista de Neurologia

Volumn 39, Issue 10, 2004, Pages 929-931

  Gil Martinez T ^a   Galiano, Rafael ^a  

^a HOSPITAL GENERAL DE REQUENA   (Spain)

Author keywords

Cerebral ischemia; Dihydroergotamine; Ergotamine; Migraine; Transient global amnesia

Indexed keywords

ANALGESIC AGENT; CAFFEINE; DIHYDROERGOTAMINE; ERGOT ALKALOID; ERGOTAMINE; FLUNARIZINE; PARACETAMOL; PAROXETINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG UTILIZATION; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MEMORY DISORDER; MIGRAINE; NAUSEA AND VOMITING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; TRANSIENT GLOBAL AMNESIA; VASOCONSTRICTION;

EID: 10444279117     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3910.2004108     Document Type: Article

References (22)

1. Caplan LB. Transient global amnesia. In Vinken PJ, Bruyn GW, Klamans HL, eds. Handbook of clinical neurology. Amsterdam: Elsevier; 1985. p. 205-18.
2. Zarranz JJ. Neurología. Madrid: Elsevier; 2003. p. 223-4.
3. Adams RD, Víctor M, Ropper AH. Principios de neurología. 6 ed. México DF: McGraw-Hill Interamericana; 1998. p. 375-6.
4. Miller JW, Petersen RC, Metter EJ, Millikan CH, Yanagihara T. Transient global amnesia: clinical characteristics and prognosis. Neurology 1987; 37: 733-7.
5. Tudurí I, Carneado J, Fragroso M, Oirtz P, Jiménez-Oriz C. Amnesia global transitoria y factores de riesgo vascular. Rev Neurol 2000; 30: 418-21.
6. Santas S, López del Val J, Tejero C, Íñiguez C, Lalana JM, Morales F. Amnesia global transitoria: revisión de 58 casos. Rev Neurol 2000; 30: 1113-7.
7. Hodges JR, Warlow CP. The aetilology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain 1990; 113: 639-57.
8. Morris HH, Estes ML. Traveler's amnesia. Transient global amnesia secondary to triazolam. JAMA 1987; 258: 945-6.
9. Savitz SA, Caplan LR. Transient global amnesia after sildenafil use. Neurology 2002; 59: 778.
10. Matsui M, Imamura T, Sakamoto S, Ishii K, Kazui H, Mori E. Transient global amnesia: increased signal intensity in the right hippocampus on diffusion-weighted magnetic resonance imaging. Neuroradiology 2002; 44: 235-8.
11. LaBar KS, Gitelman DR, Parrish TB, Mesulam MM. Functional changes in temporal lobe activity during transient global amnesia. Neurology 2002; 58: 638-41.
12. Gass A, Gaa J, Hirsch J, Schwartz A, Hennerici MG. Lack of evidence of acute ischemic tissue change in transient global amnesia on single-shot echo-planar diffusion-weighted MRI. Stroke 1999; 30: 2070-2.
13. Jiménez-Caballero PE, Marsal-Alonso C, Velázquez- Pérez JM, Álvarez-Tejerina A. Ecografía Doppler transcraneal durante una amnesia global transitoria. Rev Neurol 2003; 37: 1114-6.
14. Gorji A. Spreading depression: a review of the clinical relevance. Brain Res Rev 2001; 38: 33-60.
15. Caplan RL, Chedru F, Lhermitte F, Meiman C. Transient global amnesia and migraine. Neurology 1981; 31: 1167-70.
16. Miller JW, Yanagihara T, Peterson RC, Klass DW. Transient global amnesia and epilepsy. Electroencephalographic distinction. Arch Neurol 1987; 44: 629-33.
17. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez JM, Henry P, et al. Ergotamine in the acute treatment of migraine. A review and European consensus. Brain 2000; 123: 9-18.
18. Silberstein SD, Hargreaves RJ. Historia y farmacología de la ergotamina y la dihidroergotamina. In Diener HC, ed. Tratamiento farmacológico de la migraña y otras cefaleas. Barcelona: Year Book; 2001. p. 52-65.
19. Lewis SL. Aetiology of transient global amnesia. Lancet 1998; 352: 1557-8.
20. De Maribes H, Welzol D, de Mardes A, Klotz U, T'iedjon KU, Knaiup G. Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing. Eur J Clin Pharmacol 1986; 30: 685-9.
21. Aellig WH, Rosenthaler J. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration. Eur J Clin Pharmacol 1986; 30: 581-4.
22. Trillet M, Croisile B, Philippon B, Vial C, Laurent B, Guillot M. Ictus amnésique et débits sanguins cérébraux. Rev Neurol (Paris) 1987; 143: 536-9.